Literature DB >> 15161897

Pitfalls of converting practice guidelines into quality measures: lessons learned from a VA performance measure.

Louise C Walter1, Natalie P Davidowitz, Paul A Heineken, Kenneth E Covinsky.   

Abstract

The Department of Veterans Affairs (VA) manages the largest health care system in the United States, and the Institute of Medicine has recommended that many practices of VA quality measurement be applied to the US health care system as a whole. The VA measures quality of care at all of its sites by assessing adherence rates to performance measures, which generally are derived from evidence-based practice guidelines. Higher adherence rates are used as evidence of better quality of care. However, there are problems with converting practice guidelines, intended to offer guidance to clinicians, into performance measures that are meant to identify poor-quality care. We suggest a more balanced perspective on the use of performance measures to define quality by delineating conceptual problems with the conversion of practice guidelines into quality measures. Focusing on colorectal cancer screening, we use a case study at 1 VA facility to illustrate pitfalls that can cause adherence rates to guideline-based performance measures to be poor indicators of the quality of cancer screening. Pitfalls identified included (1) not properly considering illness severity of the sample population audited for adherence to screening, (2) not distinguishing screening from diagnostic procedures when setting achievable target screening rates, and (3) not accounting for patient preferences or clinician judgment when scoring performance measures. For many patients with severe comorbid illnesses or strong preferences against screening, the risks of colorectal cancer screening outweigh the benefits, and the decision to not screen may reflect good quality of care. Performance measures require more thoughtful specification and interpretation to avoid defining high testing rates as good quality of care regardless of who received the test, why it was performed, or whether the patient wanted it.

Entities:  

Mesh:

Year:  2004        PMID: 15161897     DOI: 10.1001/jama.291.20.2466

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  70 in total

1.  The double edged sword of performance measurement.

Authors:  Kenneth W Kizer; Susan R Kirsh
Journal:  J Gen Intern Med       Date:  2012-04       Impact factor: 5.128

2.  A shared treatment decision-making approach between patients with chronic conditions and their clinicians: the case of diabetes.

Authors:  Victor M Montori; Amiram Gafni; Cathy Charles
Journal:  Health Expect       Date:  2006-03       Impact factor: 3.377

3.  Maximizing informed cancer screening decisions.

Authors:  Louise C Walter; Carmen L Lewis
Journal:  Arch Intern Med       Date:  2007-10-22

4.  Quality assurance in oncology.

Authors:  Maurie Markman
Journal:  Curr Oncol Rep       Date:  2006-05       Impact factor: 5.075

5.  Exploring clinician adoption of a novel evidence request feature in an electronic medical record system.

Authors:  Rebecca N Jerome; Nunzia Bettinsoli Giuse; S Trent Rosenbloom; Patrick G Arbogast
Journal:  J Med Libr Assoc       Date:  2008-01

6.  Should we use large scale healthcare interventions without clear evidence that benefits outweigh costs and harms? No.

Authors:  C Seth Landefeld; Kaveh G Shojania; Andrew D Auerbach
Journal:  BMJ       Date:  2008-06-07

7.  Patient outcomes and evidence-based medicine in a preferred provider organization setting: a six-year evaluation of a physician pay-for-performance program.

Authors:  Amanda S Gilmore; Yingxu Zhao; Ning Kang; Kira L Ryskina; Antonio P Legorreta; Deborah A Taira; Richard S Chung
Journal:  Health Serv Res       Date:  2007-12       Impact factor: 3.402

8.  Variations in Guideline-Concordant Breast Cancer Adjuvant Therapy in Rural Georgia.

Authors:  Gery P Guy; Joseph Lipscomb; Theresa W Gillespie; Michael Goodman; Lisa C Richardson; Kevin C Ward
Journal:  Health Serv Res       Date:  2014-12-10       Impact factor: 3.402

9.  Using a multifaceted approach to improve the follow-up of positive fecal occult blood test results.

Authors:  Hardeep Singh; Himabindu Kadiyala; Gayathri Bhagwath; Anila Shethia; Hashem El-Serag; Annette Walder; Maria E Velez; Laura A Petersen
Journal:  Am J Gastroenterol       Date:  2009-03-17       Impact factor: 10.864

Review 10.  The unintended consequences of quality improvement.

Authors:  Naomi S Bardach; Michael D Cabana
Journal:  Curr Opin Pediatr       Date:  2009-12       Impact factor: 2.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.